Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

Autor: Van 'T Veer, Laura, Drukker, CA, Nijenhuis, MV, Bueno-de-Mesquita, JM, Retel, VP, van, WH, van, H, Wesseling, J, Schmidt, MK, van't, LJ, Sonke, GS

Publikováno v: Van 'T Veer, Laura; Drukker, CA; Nijenhuis, MV; Bueno-de-Mesquita, JM; Retel, VP; van, WH; et al.(2014). Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4st3j4pq

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::33b8295d461ff21411922428737ec21c
http://www.escholarship.org/uc/item/4st3j4pq

Genexpressieprofielen als prognostische en predictieve tests

Autor: van de Vijver, MJ, Bueno-de-Mesquita, JM, Berns, Els, van 't Veer, LJ (Laura), Foekens, John, Wobbes, Th., Nortier, J.W.R., Koning, C.C.E.

Publikováno v: Handboek mammacarcinoom, 143-153
STARTPAGE=143;ENDPAGE=153;TITLE=Handboek mammacarcinoom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::89145a89874750c221e87a1f722c6b29
https://pure.eur.nl/en/publications/722e8ee7-86d7-4aeb-855a-a4aea7488b6c

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

Autor: Vliek SB; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hilbers FS; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Retèl VP; Departmentment of Psycosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands., Bueno de Mesquita JM; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Addiction Medicin & Psychiatry, Brijder/Parnassia Group, The Hague, the Netherlands., Drukker CA; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Veltkamp SC; Department of Surgery, Amstelland Ziekenhuis, Amstelveen, the Netherlands., Zeillemaker AM; Department of Surgical Oncology, Alrijne Ziekenhuis, Leiderdorp, the Netherlands., Rutgers EJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, Netherlands; Trial and Data Center, Princes Maxima Centrum, Utrecht, the Netherlands., van Harten WH; Departmentment of Psycosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands., van 't Veer LJ; Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA., van de Vijver MJ; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Linn SC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: s.linn@nki.nl.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 175, pp. 169-179. Date of Electronic Publication: 2022 Sep 17.

[The future of psychiatry and the psychiatrist of the future].

Autor: Nijs MG, Bueno de Mesquita JM

Publikováno v: Tijdschrift voor psychiatrie [Tijdschr Psychiatr] 2019; Vol. 61 (3), pp. 217-223.

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms.

Autor: Drukker CA; Department of Surgical Oncology, Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, The Netherlands., Nijenhuis MV, Bueno-de-Mesquita JM, Retèl VP, van Harten WH, van Tinteren H, Wesseling J, Schmidt MK, Van't Veer LJ, Sonke GS, Rutgers EJ, van de Vijver MJ, Linn SC

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2014 Jun; Vol. 145 (3), pp. 697-705. Date of Electronic Publication: 2014 Apr 24.